Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PROSTATE CANCER TREATMENT PRODUCT
Document Type and Number:
WIPO Patent Application WO/2022/222596
Kind Code:
A1
Abstract:
A prostate cancer treatment product, comprising deslanoside and adjuvants, the concentration of deslanoside is greater than or equal to 1 mg/kg and less than or equal to 10 mg/kg, and the adjuvants comprise medical ethanol, medical grade polyethylene glycol, lubricating oil, and injection grade physiological saline.

Inventors:
DONG JINTANG (CN)
HUANG QINGQING (CN)
Application Number:
PCT/CN2022/077586
Publication Date:
October 27, 2022
Filing Date:
February 24, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV SOUTHERN SCI & TECH (CN)
International Classes:
A61K31/7048; A61K45/06; A61P13/08; A61P35/00
Foreign References:
CN113082040A2021-07-09
CN102416019A2012-04-18
CN112336687A2021-02-09
Other References:
BAI QIANG, LENG JING, CHEN FANG, ZHANG YUJIAN, ZHANG XIANSHENG, WANG YIXIN: "Inhibitory Effect of Digoxin and Deslanoside on the Proliferation of Prostate Cancer Cells", CHINESE JOURNAL OF ANDROLOGY, vol. 18, no. 2, 25 December 2004 (2004-12-25), pages 37 - 39+42, XP055979870, ISSN: 1008-0848
CHEN DA-PENG,TANG ZE-YAO,XIONG YONG-JIAN,LIN YUAN: "Recent Progress on Anti-cancer Effect of Cardiac Glycosides", CHINESE PHARMACOLOGICAL BULLETIN, vol. 27, no. 11, 25 November 2011 (2011-11-25), pages 1497 - 1499, XP055979872, ISSN: 1001-1978, DOI: 10.3969/j.issn.1001-1978.2011.11.006
Attorney, Agent or Firm:
CENFO INTELLECTUAL PROPERTY AGENCY (CN)
Download PDF: